아시아태평양의 신경자극 기기 시장 예측(2030년) : 지역별 분석 - 제품별, 용도별, 최종사용자별

The Asia Pacific neurostimulation devices market was valued at US$ 1,197.94 million in 2022 and is expected to reach US$ 2,517.30 million by 2030; it is estimated to register a CAGR of 9.7% from 2022 to 2030.

Growing Advances and Approvals for Neurostimulation Devices Drive Asia Pacific Neurostimulation Devices Market

Manufacturers are investing a significant amount in developing advanced products and technologies such as implantable neurostimulation devices. Additionally, an increase in Food and Drug Administration (FDA) approvals for novel neurostimulators with new applications are observed in the neurostimulation devices market. Following are a few advances and approvals for the neurostimulation devices, in February 2021, Mainstay Medical developed an implantable restorative neurostimulation system, ReActiv8, to treat intractable chronic low back pain. In March 2021, Abbott launched NeuroSphere, a virtual clinic designed to help deep brain stimulation patients program and reset their devices remotely from the comfort of their own homes. In January 2021, Boston Scientific Corporation released the WaveWriter Alpha, a portfolio of Spinal Cord Stimulator (SCS) systems that combine therapy options for personalized pain relief.

Therefore, the rising number of advances and approvals for neurostimulation devices is expected to provide lucrative opportunities for the neurostimulation devices market during the forecast period.

Asia Pacific Neurostimulation Devices Market Overview

The Asia Pacific neurostimulation devices market is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to be the fastest growing among all the regions. The rising awareness regarding neurological disorders among countries such as India, Australia, and South Korea defines the market's growth in the region. The neurostimulation devices market in Asia Pacific is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, innovative technology trends in neurology and the rapid adoption of artificial intelligence (AI) and machine learning (ML) are a few factors that drive the market in the region. Furthermore, supportive government initiatives and research in neurology also boost market growth.

Asia Pacific Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Neurostimulation Devices Market Segmentation

The Asia Pacific neurostimulation devices market is segmented based on product, application, end user, and country. Based on product, the Asia Pacific neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the Asia Pacific neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the Asia Pacific neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific neurostimulation devices market is segmented into the UK, China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, and Mainstay Medical are among the leading companies operating in the Asia Pacific neurostimulation devices market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Neurostimulation Devices Market - Key Industry Dynamics

• 4.1 Market Drivers
  • 4.1.1 Increasing Prevalence of Neurological Disorders
  • 4.1.2 Rising Cases of Spinal Cord Injury
• 4.2 Market Restraints
  • 4.2.1 Lack of Expert Professionals
• 4.3 Market Opportunities
  • 4.3.1 Growing Advances and Approvals for Neurostimulation Devices
• 4.4 Future Trends
  • 4.4.1 Rising Demand for Noninvasive Treatment
• 4.5 Impact Analysis

5. Neurostimulation Devices Market - Asia Pacific Market Analysis

• 5.1 Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

• 6.1 Overview
• 6.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
• 6.3 Spinal Cord Stimulator
  • 6.3.1 Overview
  • 6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Deep Brain Stimulator
  • 6.4.1 Overview
  • 6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 6.5 Sacral Nerve Stimulator
  • 6.5.1 Overview
  • 6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 6.6 Vagus Nerve Stimulator
  • 6.6.1 Overview
  • 6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 6.7 Others
  • 6.7.1 Overview
  • 6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

• 7.1 Overview
• 7.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
• 7.3 Pain Management
  • 7.3.1 Overview
  • 7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Epilepsy
  • 7.4.1 Overview
  • 7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Urinary and Fecal Incontinence
  • 7.5.1 Overview
  • 7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Parkinson's Disease
  • 7.6.1 Overview
  • 7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 7.7 Others
  • 7.7.1 Overview
  • 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

• 8.1 Overview
• 8.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
• 8.3 Hospitals
  • 8.3.1 Overview
  • 8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Specialty Clinics
  • 8.4.1 Overview
  • 8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Others
  • 8.5.1 Overview
  • 8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

• 9.1 Asia Pacific: Neurostimulation Devices Market
  • 9.1.1 Overview
  • 9.1.2 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
    • 9.1.2.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
    • 9.1.2.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.2.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 9.1.2.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 9.1.2.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 9.1.2.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
    • 9.1.2.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.2.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 9.1.2.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 9.1.2.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 9.1.2.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
    • 9.1.2.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.2.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 9.1.2.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 9.1.2.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 9.1.2.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
    • 9.1.2.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.2.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 9.1.2.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 9.1.2.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 9.1.2.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
    • 9.1.2.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.2.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 9.1.2.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 9.1.2.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 9.1.2.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
    • 9.1.2.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.1.2.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 9.1.2.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 9.1.2.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

• 10.1 Overview
• 10.2 Organic Developments
  • 10.2.1 Overview
• 10.3 Inorganic Developments
  • 10.3.1 Overview

11. Company Profiles

• 11.1 Medtronic Plc
  • 11.1.1 Key Facts
  • 11.1.2 Business Description
  • 11.1.3 Products and Services
  • 11.1.4 Financial Overview
  • 11.1.5 SWOT Analysis
  • 11.1.6 Key Developments
• 11.2 Boston Scientific Corp
  • 11.2.1 Key Facts
  • 11.2.2 Business Description
  • 11.2.3 Products and Services
  • 11.2.4 Financial Overview
  • 11.2.5 SWOT Analysis
  • 11.2.6 Key Developments
• 11.3 Abbott Laboratories
  • 11.3.1 Key Facts
  • 11.3.2 Business Description
  • 11.3.3 Products and Services
  • 11.3.4 Financial Overview
  • 11.3.5 SWOT Analysis
  • 11.3.6 Key Developments
• 11.4 Nevro Corp
  • 11.4.1 Key Facts
  • 11.4.2 Business Description
  • 11.4.3 Products and Services
  • 11.4.4 Financial Overview
  • 11.4.5 SWOT Analysis
  • 11.4.6 Key Developments
• 11.5 LivaNova Plc
  • 11.5.1 Key Facts
  • 11.5.2 Business Description
  • 11.5.3 Products and Services
  • 11.5.4 Financial Overview
  • 11.5.5 SWOT Analysis
  • 11.5.6 Key Developments
• 11.6 Mainstay Medical
  • 11.6.1 Key Facts
  • 11.6.2 Business Description
  • 11.6.3 Products and Services
  • 11.6.4 Financial Overview
  • 11.6.5 SWOT Analysis
  • 11.6.6 Key Developments

12. Appendix

• 12.1 About Us
• 12.2 Glossary of Terms